PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)
Indonesia · Delayed Price · Currency is IDR 232.00
+4.00 (1.75%)
May 26, 2026, 4:00 PM WIB
IDX:DGNS Market Cap
IDX:DGNS has a market cap or net worth of 290 billion as of May 26, 2026. Its market cap has increased by 45.00% in one year.
Market Cap
290.00B
Enterprise Value
360.52B
Revenue
171.06B
Ranking
n/a
PE Ratio
86.66
Stock Price
232.00
Market Cap Chart
Since January 15, 2021, IDX:DGNS's market cap has decreased from 337.50B to 290.00B, a decrease of -14.07%. That is a compound annual growth rate of -2.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 290.00B | 26.09% |
| Dec 30, 2025 | 230.00B | -5.64% |
| Dec 30, 2024 | 243.75B | -20.73% |
| Dec 29, 2023 | 307.50B | 0.82% |
| Dec 30, 2022 | 305.00B | -67.25% |
| Dec 30, 2021 | 931.25B | 175.93% |
| Jan 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PT Sejahteraraya Anugrahjaya Tbk | 171.35T |
| PT Kalbe Farma Tbk. | 36.20T |
| PT Siloam International Hospitals Tbk | 31.04T |
| PT Mitra Keluarga Karyasehat Tbk | 23.57T |
| PT Maja Agung Latexindo Tbk | 443.41B |
| PT Indofarma Tbk | 390.51B |
| PT Ikapharmindo Putramas Tbk | 313.35B |
| PT Royal Prima Tbk | 290.54B |